Risk Factors for Severity and Mortality in Adult Patients Confirmed with COVID-19 in Sierra Leone: A Retrospective Study
Bo Tu, Sulaiman Lakoh, Biao Xu, Marta Lado, Reginald Cole, Fang Chu, Susan Hastings-Spaine, Mohamed Bole Jalloh, Junjie Zheng, Weiwei Chen, Stephen Sevalie
Infectious Diseases & Immunity, doi:10.1097/id9.0000000000000037
Background: The coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease. There is no recommended antiviral treatment approved for COVID-19 in Sierra Leone, and supportive care and protection of vital organ function are performed for the patients. This study summarized the clinical characteristics, drug treatments, and risk factors for the severity and prognosis of COVID-19 in Sierra Leone to provide evidence for the treatment of COVID-19. Methods: Data of 180 adult COVID-19 patients from the 34th Military Hospital in Freetown Sierra Leone between March 31, 2020 and August 11, 2020 were retrospectively collected. Patients with severe and critically ill are classified in the severe group, while patients that presented asymptomatic, mild, and moderate disease were grouped in the non-severe group. The clinical and laboratory information was retrospectively collected to assess the risk factors and treatment strategies for severe COVID-19. Demographic information, travel history, clinical symptoms and signs, laboratory detection results, chest examination findings, therapeutics, and clinical outcomes were collected from each case file. Multivariate logistic analysis was adopted to identify the risk factors for deaths. Additionally, the clinical efficacy of dexamethasone treatment was investigated. Results: Seventy-six (42.22%) cases were confirmed with severe COVID-19, while 104 patients (57.78%) were divided into the non-severe group. Fever (56.67%, 102/180) and cough (50.00%, 90/180) were the common symptoms of COVID-19. The death rate was 18.89% (34/180), and severe pneumonia (44.12%, 15/34) and septic shock (23.53%, 8/34) represented the leading reasons for deaths. The older age population, a combination of hypertension and diabetes, the presence of pneumonia, and high levels of inflammatory markers were significantly associated with severity of COVID-19 development (P < 0.05 for all). Altered level of consciousness [odds ratio (OR) = 56.574, 95% confidence interval (CI) 5.645-566.940, P = 0.001], high levels of neutrophils (OR = 1.341, 95%CI 1.109-1.621, P = 0.002) and C-reactive protein (CRP) (OR = 1.014, 95%CI 1.003-1.025, P = 0.016) might be indicators for COVID-19 deaths. Dexamethasone treatment could reduce mortality [30.36% (17/56) vs. 50.00% (10/20)] among severe COVID-19 cases, but the results were not statistically significant (P > 0.05).
Conclusions: The development and prognosis of COVID-19 may be significantly correlated with consciousness status, and the levels of neutrophils and CRP.
Author Contributions Bo Tu, Biao Xu, and Weiwei Chen designed, drafted the manuscript. Marta Lado, Reginald Cole, Fang Chu, Susan Hastings-Spaine, and Mohamed Boie Jalloh contributed to the acquisition and analysis of the data. Junjie Zheng, Sulaiman Lakoh, and Stephen Sevalie conceived the manuscript and substantively revised it. All authors revised and approved the final manuscript.
of Interest None.
Committee, Cnh, Diagnosis and treatment of pneumonia caused by 2019-nCoV (version 7)
Esposito, Noviello, Pagliano, Update on treatment of COVID-19: ongoing studies between promising and disappointing results, Infez Med
Guo, Cao, Hong, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status, Mil Med Res, doi:10.1186/s40779-020-00240-0
Horby, Lim, Emberson, Dexamethasone in hospitalized patients with covid-19-preliminary report, N Engl J Med, doi:10.1056/NEJMoa2021436
Kumar, Arora, Sharma, Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis, Diabetes Metab Syndr, doi:10.1016/j.dsx.2020.04.044
Lai, Shih, Ko, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges, Int J Antimicrob Agents, doi:10.1016/j.ijantimicag.2020.105924
Li, Guan, Wu, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N Engl J Med, doi:10.1056/NEJMoa2001316
Li, Huang, Wang, COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis, J Med Virol, doi:10.1002/jmv.25757
Lian, Hao, Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China, Influenza Other Resp, doi:10.1111/irv.12758
Liu, Li, Feng, Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China, Crit Care, doi:10.1186/s13054-020-2786-x
Lo, Lio, Cheong, Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau, Int J Biol Sci, doi:10.7150/ijbs.45357
Song, Zhang, Yin, COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2), Int J Antimicrob Agents, doi:10.1016/j.ijantimicag.2020.106080
Su, Lai, Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan, Travel Med Infect Dis, doi:10.1016/j.tmaid.2020.101625
Tabata, Imai, Kawano, Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis, Lancet Infect Dis, doi:10.1016/S1473-3099(20)30482-5
Tomazini, Maia, Cavalcanti, Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial, JAMA, doi:10.1001/jama.2020.17021
Wang, Hou, Luo, The laboratory tests and host immunity of COVID-19 patients with different severity of illness, JCI Insight, doi:10.1172/jci.insight.137799
Who, Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected
Wiersinga, Rhodes, Cheng, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review, JAMA, doi:10.1001/jama.2020.12839
Xu, Ong, Wang, Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines, Mil Med Res, doi:10.1186/s40779-020-00251-x
Zhand, Jazi, Mohammadi, COVID-19: the immune responses and clinical therapy candidates, Int J Mol Sci, doi:10.3390/ijms21155559
Zheng, SARS-CoV-2: an emerging coronavirus that causes a global threat, Int J Biol Sci, doi:10.7150/ijbs.45053